151 related articles for article (PubMed ID: 17577040)
1. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials.
Carson KA; Grossman SA; Fisher JD; Shaw EG
J Clin Oncol; 2007 Jun; 25(18):2601-6. PubMed ID: 17577040
[TBL] [Abstract][Full Text] [Related]
2. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.
Ruden E; Reardon DA; Coan AD; Herndon JE; Hornsby WE; West M; Fels DR; Desjardins A; Vredenburgh JJ; Waner E; Friedman AH; Friedman HS; Peters KB; Jones LW
J Clin Oncol; 2011 Jul; 29(21):2918-23. PubMed ID: 21690470
[TBL] [Abstract][Full Text] [Related]
3. Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.
De Vleeschouwer S; Ardon H; Van Calenbergh F; Sciot R; Wilms G; van Loon J; Goffin J; Van Gool S
Cancer Immunol Immunother; 2012 Nov; 61(11):2105-12. PubMed ID: 22565485
[TBL] [Abstract][Full Text] [Related]
4. MRI tumor response and clinical outcomes after LINAC radiosurgery on 50 patients with recurrent malignant gliomas.
Khalil T; Lemaire JJ; Dedieu V; Donnarieix D; Béatrice C; Lapeyre M; Kemeny JL; Pereira B; Thalami A; Chazal J; Verrelle P
J Radiosurg SBRT; 2013; 2(4):291-305. PubMed ID: 29296372
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Nanomedicine in Glioblastoma Treatment: Clinical Efficacy, Safety, and Future Directions.
Farooq M; Scalia G; Umana GE; Parekh UA; Naeem F; Abid SF; Khan MH; Zahra SG; Sarkar HP; Chaurasia B
Brain Sci; 2023 Dec; 13(12):. PubMed ID: 38137175
[TBL] [Abstract][Full Text] [Related]
6. Clinical Theranostics in Recurrent Gliomas: A Review.
Hoggarth AR; Muthukumar S; Thomas SM; Crowley J; Kiser J; Witcher MR
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730666
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors to predict postoperative survival in patients with recurrent glioblastoma.
Hansen ST; Jacobsen KS; Kofoed MS; Petersen JK; Boldt HB; Dahlrot RH; Schulz MK; Poulsen FR
World Neurosurg X; 2024 Jul; 23():100308. PubMed ID: 38584878
[TBL] [Abstract][Full Text] [Related]
8. Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation.
Dutta D; Jose M; Kalavagunta S; Sasidharan A; Nair H; Edappattu AH
Radiat Oncol J; 2024 Mar; 42(1):32-42. PubMed ID: 38549382
[TBL] [Abstract][Full Text] [Related]
9. Nomogram incorporating preoperative MRI-VASARI features for differentiating intracranial extraventricular ependymoma from glioblastoma.
Yao Y; Fu Y; Zhou G; Wang X; Li L; Mao Y; Wang J; Tan Z; Jiang M; Yi X; Chen BT
Quant Imaging Med Surg; 2024 Mar; 14(3):2255-2266. PubMed ID: 38545063
[TBL] [Abstract][Full Text] [Related]
10. The current status and novel advances of boron neutron capture therapy clinical trials.
Zhou T; Igawa K; Kasai T; Sadahira T; Wang W; Watanabe T; Bekku K; Katayama S; Iwata T; Hanafusa T; Xu A; Araki M; Michiue H; Huang P
Am J Cancer Res; 2024; 14(2):429-447. PubMed ID: 38455422
[TBL] [Abstract][Full Text] [Related]
11. The involvement of brain regions associated with lower KPS and shorter survival time predicts a poor prognosis in glioma.
Bao H; Wang H; Sun Q; Wang Y; Liu H; Liang P; Lv Z
Front Neurol; 2023; 14():1264322. PubMed ID: 38111796
[TBL] [Abstract][Full Text] [Related]
12. The application of decision tree model based on clinicopathological risk factors and pre-operative MRI radiomics for predicting short-term recurrence of glioblastoma after total resection: a retrospective cohort study.
Du P; Wu X; Liu X; Chen J; Chen L; Cao A; Geng D
Am J Cancer Res; 2023; 13(8):3449-3462. PubMed ID: 37693142
[TBL] [Abstract][Full Text] [Related]
13. Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?
Clavreul A; Autier L; Lemée JM; Augereau P; Soulard G; Bauchet L; Figarella-Branger D; Menei P; Network F;
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428604
[TBL] [Abstract][Full Text] [Related]
14. Doramectin inhibits glioblastoma cell survival via regulation of autophagy
Chen C; Liang H; Qin R; Li X; Wang L; Du S; Chen Z; Meng X; Lv Z; Wang Q; Meng J; Gao A
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35137919
[TBL] [Abstract][Full Text] [Related]
15. Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome.
Lu L; Hu Y; Wang C; Jiang F; Wu C
Front Mol Biosci; 2021; 8():747933. PubMed ID: 34869584
[No Abstract] [Full Text] [Related]
16. Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
Aldaz P; Arozarena I
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830952
[TBL] [Abstract][Full Text] [Related]
17. Comparison of carbon ion and photon reirradiation for recurrent glioblastoma.
Lautenschlaeger FS; Dumke R; Schymalla M; Hauswald H; Carl B; Stein M; Keber U; Jensen A; Engenhart-Cabillic R; Eberle F
Strahlenther Onkol; 2022 May; 198(5):427-435. PubMed ID: 34523017
[TBL] [Abstract][Full Text] [Related]
18. Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study.
Kawabata S; Suzuki M; Hirose K; Tanaka H; Kato T; Goto H; Narita Y; Miyatake SI
Neurooncol Adv; 2021; 3(1):vdab067. PubMed ID: 34151269
[TBL] [Abstract][Full Text] [Related]
19. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma.
Qiu X; Tian Y; Xu J; Jiang X; Liu Z; Qi X; Chang X; Zhao J; Huang J
J Cancer; 2021; 12(14):4264-4276. PubMed ID: 34093827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
